Prohydrojasmon
CAS No. 158474-72-7
Prohydrojasmon( Prohydrojasmon racemate | Propyl dihydrojasmonate )
Catalog No. M20650 CAS No. 158474-72-7
Prohydrojasmon is a synthesized plant gowth regulator which has jasmonic acid activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 33 | In Stock |
|
| 500MG | 55 | In Stock |
|
| 1G | 82 | In Stock |
|
Biological Information
-
Product NameProhydrojasmon
-
NoteResearch use only, not for human use.
-
Brief DescriptionProhydrojasmon is a synthesized plant gowth regulator which has jasmonic acid activity.
-
DescriptionProhydrojasmon is a synthesized plant gowth regulator which has jasmonic acid activity.
-
In VitroProhydrojasmon racemate (n-propyl dihydrojasmonate, PDJ) is a functional analogue of Jasmonic acid (JA) . Prohydrojasmon racemate (n-propyl dihydrojasmonate, PDJ) is a plant growth promoter.
-
In Vivo——
-
SynonymsProhydrojasmon racemate | Propyl dihydrojasmonate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number158474-72-7
-
Formula Weight254.37
-
Molecular FormulaC15H26O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:54 mg/mL (212.29 mM)
-
SMILESCCCCCC1C(CC(=O)OCCC)CCC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cohen S Barer F Itzhak I et al. Effect of prohydrojasmon on total phenolic content anthocyanin accumulation and antioxidant activity in komatsuna and lettuce[J].J Immunol Res. 2018 May 15;2018:2310970.
molnova catalog
related products
-
proPT18
proPT18
-
Egg yolk phosphatidy...
Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
-
IGF-II (33-40)
IGF-II (33-40)
Cart
sales@molnova.com